Generative AI (GenAI) is a subset of artificial intelligence (AI) that uses training data to produce new content, including text, images, audio, video, and software code. Its use is becoming increasingly prevalent as organisations seek to increase productivity and drive growth through the efficiencies in time, resources and cost which GenAI offers.
The purpose of this white paper is to explain on a largely jurisdiction-neutral basis critical contractual issues and risks to consider in relation to GenAI procurement and give an overview of some of the key steps an organisation should consider to address and mitigate these issues and risks effectively.
According to a Deloitte survey in 2024, over 79% of CEOs expect GenAI to transform their organisations in the next three years. Alongside the opportunities that it creates, however, GenAI presents numerous legal, ethical, and operational challenges. These include the creation of content that may infringe third party intellectual property rights, data privacy and security concerns, the risk of bias in the materials GenAI produces, and the increasingly complex web of law and regulation which impacts GenAI. As the prevalence of GenAI continues to grow, it is becoming increasingly important to manage the risks associated with GenAI, both when procuring it for direct use and when GenAI is used in the supply chain.
Key legal issues in connection with GenAI
The introduction of GenAI in companies raises a number of legal issues that need to be considered when procuring and using this technology:
Contractual requirements for the procurement of GenAI systems
When procuring GenAI systems, companies should consider a number of specific risks in their contracts:
Managing GenAI risks in the supply chain
The use of GenAI by suppliers and service providers in connection with the development and delivery of the services and products that they supply to customers needs to be carefully evaluated within the context of the existing supply chain, and managed on an ongoing basis. The introduction of GenAI systems can give rise to additional legal and operational risks that have not previously been considered. This also underscores the need for organisations to understand clearly how the goods and services they procure are sourced and delivered.
Putting theory into practice
To effectively manage the risks discussed in this white paper, companies need to adapt their standard contract templates and redesign their procurement processes to recognize and cover GenAI-specific risks early on.
For more information or assistance in addressing the challenges and opportunities presented by GenAI, our experts at Deloitte Legal are at your disposal. Please do not hesitate to contact us to find out more about how we can support your business.
Contact persons: Dr Till Contzen | Partner, Service Area Head Digital Law, Deloitte Legal Germany; Paul O’Hare | Partner, Commercial Technology Advisory, Deloitte Legal UK; Louis Wihl | Director, Commercial Technology Advisory, Deloitte Legal UK; Elizabeth Lumb | Associate Director, Commercial Technology Advisory, Deloitte Legal UK